This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Brainstorm Cell Therapeutics Ltd.. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Yosef Levy: Innovator in Mesenchymal Stem Cell Research
Introduction
Yosef Levy is a prominent inventor based in Modiin, Israel. He has made significant contributions to the field of stem cell research, particularly focusing on mesenchymal stem cells (MSCs) and their therapeutic potential. With a total of 2 patents, Levy's work is paving the way for advancements in regenerative medicine.
Latest Patents
Levy's latest patents include innovative methods related to mesenchymal stem cells. The first patent, titled "Populations of mesenchymal stem cells that secrete neurotrophic factors," discloses a method for qualifying whether a cell population is suitable for therapeutic use. The second patent, "Methods of generating mesenchymal stem cells which secrete neurotrophic factors," outlines a process for generating MSCs that secrete neurotrophic factors (NTFs) by incubating a population of undifferentiated MSCs in a differentiating medium containing basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), heregulin, and cAMP.
Career Highlights
Levy is currently associated with Brainstorm Cell Therapeutics Ltd., a company dedicated to developing innovative therapies for neurodegenerative diseases. His work at the company emphasizes the importance of MSCs in therapeutic applications, showcasing his commitment to advancing medical science.
Collaborations
Levy collaborates with notable colleagues, including Yael Gothelf and Alex Burshtein. Their combined expertise contributes to the innovative research and development efforts at Brainstorm Cell Therapeutics Ltd.
Conclusion
Yosef Levy's contributions to mesenchymal stem cell research are noteworthy, with his patents reflecting a commitment to advancing therapeutic methods. His work continues to inspire innovation in the field of regenerative medicine.